Viral Vector Services

Experience

• We offer 14+ years of experience developing processes and producing cGMP viral vectors: AAV, Adenovirus, Lentivirus, HSV, and Retrovirus.
• We’ve produced 60+ viral vector products and 150+ cGMP clinical or commercial batches using a variety of manufacturing technologies.

Solutions

• Our deep technical and analytical expertise overcome challenges associated with these complex products.
• Single-use equipment allows maximum flexibility for manufacturing platform, scale and project scheduling while ensuring product quality.

Capabilities and Capacity

• Continued expansion of our cGMP-compliant, state-of-the-art, multi-product facilities ensures the support our clients without long queues.
• Our 750+ innovative employees are focused on serving the needs of clients and their patients.

Quality

• Quality is at the core of everything we do and we’ve earned the trust of clients around the world.
• Our Quality Management System is specifically designed to ensure regulatory compliance and the highest product quality possible.

An Extension of Your Team

• Our collaborative approach keeps clients involved, engaged and well-informed as we strive to exceed their expectations.
• We operate with transparency and flexibility because every client is unique and each patient matters.

Patient-Focused

• We enable emerging biotech and large pharma customers to deliver breakthrough medicines to patients by unleashing the potential of cell and gene therapy.
• We are uniquely positioned to partner with our clients to drive the innovation in this incredibly fast-growing market to reach even more patients and treat even more indications.